Canadá - inglés - Health Canada

sandoz canada incorporated - hydromorphone hydrochloride - solution - 2mg - hydromorphone hydrochloride 2mg - opiate agonists

Canadá - inglés - Health Canada

sterimax inc - hydromorphone hydrochloride - solution - 2mg - hydromorphone hydrochloride 2mg - opiate agonists

Estados Unidos - inglés - NLM (National Library of Medicine)

purdue pharma lp - hydromorphone hydrochloride (unii: l960up2krw) (hydromorphone - unii:q812464r06) - hydromorphone hydrochloride 1 mg in 1 ml - dilaudid injection is indicated for the management of pain severe enough to require an opioid analgesic and for which alternate treatments are inadequate. dilaudid-hp injection is indicated for use in opioid-tolerant patients who require higher doses of opioids for the management of pain severe enough to require an opioid analgesic and for which alternate treatments are inadequate. patients considered opioid tolerant are those who are taking for one week or longer, around-the-clock medicine consisting of at least 60 mg oral morphine per day, or at least 25 mcg transdermal fentanyl per hour, or at least 30 mg oral oxycodone per day, or at least 8 g oral hydromorphone per day, or at least 25 mg oral oxymorphone per day, or at least 60 mg oral hydrocodone per day. or an equianalgesic dose of another opioid for one week or longer. patients must remain on around-the-clock opioids while administering dilaudid-hp. limitations of use: because of the risks of addiction, abuse, and misuse with opioids, even at recommen

Canadá - inglés - Health Canada

fresenius kabi canada ltd - hydromorphone hydrochloride - solution - 10mg - hydromorphone hydrochloride 10mg - opiate agonists

Canadá - inglés - Health Canada

fresenius kabi canada ltd - hydromorphone hydrochloride - solution - 2mg - hydromorphone hydrochloride 2mg - opiate agonists

Canadá - inglés - Health Canada

sandoz canada incorporated - hydromorphone hydrochloride - solution - 1mg - hydromorphone hydrochloride 1mg - opiate agonists

Canadá - inglés - Health Canada

jamp pharma corporation - hydromorphone hydrochloride - solution - 2mg - hydromorphone hydrochloride 2mg

Canadá - inglés - Health Canada

sterimax inc - hydromorphone hydrochloride - solution - 1mg - hydromorphone hydrochloride 1mg

Estados Unidos - inglés - NLM (National Library of Medicine)

specgx llc - hydromorphone hydrochloride (unii: l960up2krw) (hydromorphone - unii:q812464r06) - hydromorphone hydrochloride 8 mg - exalgo is indicated for the management of pain in opioid-tolerant patients severe enough to require daily, around-the-clock, long-term opioid treatment and for which alternative treatment options are inadequate. patients considered opioid tolerant are those who are receiving, for one week or longer, at least 60 mg oral morphine per day, 25 mcg transdermal fentanyl per hour, 30 mg oral oxycodone per day, 8 mg oral hydromorphone per day, 25 mg oral oxymorphone per day, 60 mg oral hydrocodone per day, or an equianalgesic dose of another opioid. limitations of use - because of the risks of addiction, abuse, and misuse with opioids, even at recommended doses, and because of the greater risks of overdose and death with extended-release opioid formulations, reserve exalgo for use in patients for whom alternative treatment options (e.g., non-opioid analgesics or immediate-release opioids) are ineffective, not tolerated, or would be otherwise inadequate to provide sufficient management of pain. because of the risks

Canadá - inglés - Health Canada

pfizer canada ulc - hydromorphone hydrochloride - solution - 10mg - hydromorphone hydrochloride 10mg - opiate agonists